The haemodynamic effects of rocuronium and vecuronium are different under balanced anaesthesia

Acta Anaesthesiologica Scandinavica

Volumn 41, Issue 4, 1997, Pages 502-505

  Stevens, J B ^a   Hecker, R B ^a   Talbot, J C ^a   Walker, S C ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

Neuromuscular relaxants: Pancuronium, Rocuronium, vecuronium

Indexed keywords

FENTANYL; ISOFLURANE; NITROUS OXIDE; PANCURONIUM; ROCURONIUM; VECURONIUM;

ADULT; ANESTHESIA; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART RATE; HEMODYNAMICS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030977189     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1997.tb04731.x     Document Type: Article

References (16)

1. Cooper R, Mirakhur RK, Clarke RSJ, Boules Z. Comparison of intubating conditions after administration of ORG 9426 (rocuronium) and suxamethonium. Br J Anaesth 1992: 69: 269-273.
2. Booij LHDJ, Knape HTA. The neuromuscular blocking effect of ORG 9426. A new intermediately-acting steroidal nondepolarizing muscle relaxant in man. Anaesthesia 1991: 46: 341-343.
3. Wierda JMKH, De Wit APM, Kuizenga K, Agoston S. Clinical observations on the neuromuscular blocking action of ORG 9426, a new steroidal nondepolarizing agent. Br J Anaesth 1990: 64: 521-523.
4. 2-sufentanil anesthesia. Anesth Analg 1994: 78: 318-321.
5. Muir AW, Houston J, Green KL, Marshall RJ, Bowman WC, Marshall IG. Effects of a new neuromuscular blocking agent (ORG 9426) in anesthetized cats and pigs and in isolated nerve-muscle preparations. Br J Anaesth 1989: 63: 400-410.
6. Morris RB, Cahalan MK, Miller RD, Wilkinson PL, Quasha AL, Robinson SL. The cardiovascular effects of vecuronium (ORG NC45) and pancuronium in patients undergoing coronary artery bypass grafting. Anesthesiology 1983: 58: 438-440.
7. Tullock WC, Diana P, Cook DR, Wilks DH, Brandom BW, Stiller RL et al. Neuromuscular and cardiovascular effects of high-dose vecuronium. Anesth Analg 1990: 70: 86-90.
8. Starr NJ, Sethna DH, Estafanous FG. Bradycardia and asystole following the rapid administration of sufentanil with vecuronium. Anesthesiology 1986: 64: 521-523.
9. Clayton D. Asystole associated wth vecuronium. Br J Anaesth 1986: 58: 937-938.
10. Ferres CJ, Carson IW, Lyons SM, Orr IA, Patterson CC, Clarke RS. Haemodynamic effects of vecuronium, pancuronium, and atracurium in patients with coronary artery disease. Br J Anaesth 1987: 59: 305-311.
11. Miller RD, Eger EI, Stevens WC. Pancuronium induced tachycardia in relation to alveolar halothane, dose of pancuronium, and prior atropine. Anesthesiology 1975: 42: 352-355.
12. Stoelting RK. The hemodynamic effects of pancuronium and d-tubocurarine in anesthetized patients. Anesthesiology 1972: 36: 612-615.
13. Naguib M, Samarkandi AH, Bakhamees HS, Magboul MA, El-Bakry AK. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine. Br J Anaesth 1995: 75: 588-592.
14. McCoy EP, Maddineni VR, Elliott P, Mirakhur RK, Carson IW, Cooper RA. Haemodynamic effects of rocuronium during fentanyl anaesthesia: comparison with vecuronium. Can J Anaesth 1993: 40: 703-708.
15. Booth MG, Marsh B, Bryden FMM, Robertson EN, Baird WLM. A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia. Anaesthesia 1992: 47: 332-334.
16. Cason B, Baker DC, Hickey RF, Miller RD, Agoston S. Cardiovascular and neuromuscular effects of three steroid neuromuscular blocking drugs in dogs (ORG 9616, ORG 9426, ORG 9991). Anesth Analg 1990: 70: 382-388.